Progression-directed ablative radiotherapy improves event-free survival in oligoprogressive NSCLC
IntroductionTo assess the efficacy of progression-directed radiation therapy (PDRT) in patients with oligoprogressive non-small cell lung cancer (NSCLC), with particular focus on disease progression and changes in systemic therapy.Materials and methodsFrom January 2020 to October 2025, a retrospecti...
Zapisane w:
| Główni autorzy: | , , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
Frontiers Media S.A.
2026-05-01
|
| Seria: | Frontiers in Oncology |
| Hasła przedmiotowe: | |
| Dostęp online: | https://www.frontiersin.org/articles/10.3389/fonc.2026.1766544/full |
| Etykiety: |
Nie ma etykietki, Dołącz pierwszą etykiete!
|
